Search - tctmd.com

Displaying 1 - 20 of 24

Sort: Relevancy | Date

News Opinion CV Team Dispatch

September 2024 Dispatch for the CV Team

L.A. McKeown

September 01, 2024

News Opinion CV Team Dispatch

May 2024 Dispatch for the CV Team

L.A. McKeown

May 01, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Conference News ISET 2024

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

Caitlin E. Cox

January 24, 2024

News Opinion CV Team Dispatch

January 2024 Dispatch for the CV Team

L.A. McKeown

January 01, 2024

News Opinion CV Team Dispatch

October 2023 News Roundup

L.A. McKeown

October 01, 2023

News Opinion CV Team Dispatch

September 2023 News Roundup

L.A. McKeown

September 01, 2023

News Daily News

Only Half of Revascularized PAD Patients Receive GDMT

L.A. McKeown

February 14, 2023

News Daily News

Worse Complications After PVI in Women Highlight Research Gaps

L.A. McKeown

August 16, 2022

News Daily News

PAD Significantly Ups Morbidity and Mortality in AMICS

L.A. McKeown

March 29, 2022

News Opinion CV Team Dispatch

February 2022 News Roundup

L.A. McKeown

February 01, 2022

News Opinion CV Team Dispatch

June 2021 News Roundup

L.A. McKeown

June 01, 2021

News Conference News VIVA 2020

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

L.A. McKeown

November 09, 2020

News Daily News

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Caitlin E. Cox

October 16, 2019

News Conference News SCAI 2019

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

Yael L. Maxwell

May 21, 2019

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2018

Shelley Wood

March 01, 2018

News Features

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

Shelley Wood

December 30, 2016

News Daily News

EUCLID:替卡格雷相比氯吡格雷对有症状 PAD 患者预防心血管事件没有更大的好处

Shelley Wood

October 07, 2016

News Daily News

EUCLID: Ticagrelor Holds No Edge Over Clopidogrel for Preventing Atherothrombotic Events in Symptomatic PAD Patients

Shelley Wood

October 07, 2016

News Daily News

Ensayo EUCLID: Ticagrelor No es Más Beneficioso que Clopidogrel en la Prevención de Episodios CV en Pacientes con EAP Sintomática

Shelley Wood

October 07, 2016

Advertisement

September 2024 Dispatch for the CV Team

May 2024 Dispatch for the CV Team

March 2024 Dispatch for the CV Team

How to Reconcile BEST-CLI and BASIL-2? A ‘Patient-First’ Strategy

January 2024 Dispatch for the CV Team

October 2023 News Roundup

September 2023 News Roundup

Only Half of Revascularized PAD Patients Receive GDMT

Worse Complications After PVI in Women Highlight Research Gaps

PAD Significantly Ups Morbidity and Mortality in AMICS

February 2022 News Roundup

June 2021 News Roundup

DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD

Bleeding Risk Similar for Peripheral, Coronary Revascularization: EUCLID

Paclitaxel DCBs and CHIP: SCAI Kicks Off With Two Hot-Potato Topics

TCTMD’s Top 10 Most Popular Stories for February 2018

Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond

EUCLID:替卡格雷相比氯吡格雷对有症状 PAD 患者预防心血管事件没有更大的好处

EUCLID: Ticagrelor Holds No Edge Over Clopidogrel for Preventing Atherothrombotic Events in Symptomatic PAD Patients

Ensayo EUCLID: Ticagrelor No es Más Beneficioso que Clopidogrel en la Prevención de Episodios CV en Pacientes con EAP Sintomática

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content